TORONTO, Sept. 27 /CNW/ - Spectral Diagnostics Inc. (TSX:SDI) today
announced the co-sponsorship with Toray Medical Company (Tokyo, Japan) of a
key scientific session at SEPSIS 2007, an International Symposium held at the
Institut Pasteur in Paris, France from September 26-29th, 2007. "Endotoxemia -
Detection, Consequence and Intervention" will feature a panel of four thought
leaders in the field of sepsis discussing the value of Spectral's EAA(TM)
Endotoxin Activity Assay. The EAA(TM) is the only FDA cleared, whole blood
assay for the detection of endotoxemia.
